These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16681171)

  • 1. A profile of Ecstasy (MDMA) use in São Paulo, Brazil: an ethnographic study.
    Battisti MC; Noto AR; Nappo S; Carlini Ede A
    J Psychoactive Drugs; 2006 Mar; 38(1):13-8. PubMed ID: 16681171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecstasy (MDMA): effects and patterns of use reported by users in São Paulo.
    de Almeida SP; Silva MT
    Braz J Psychiatry; 2003 Mar; 25(1):11-7. PubMed ID: 12975674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    McCaughan JA; Carlson RG; Falck RS; Siegal HA
    Subst Use Misuse; 2005; 40(9-10):1503-23. PubMed ID: 16048830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
    Carlson RG; Falck RS; McCaughan JA; Siegal HA
    J Psychoactive Drugs; 2004 Jun; 36(2):181-9. PubMed ID: 15369199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
    Engels RC; ter Bogt T
    Eur Addict Res; 2004; 10(4):156-62. PubMed ID: 15367816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ecstasy users in Sãio Paulo, Brazil.
    De Almeida SP; Silva MT
    Subst Use Misuse; 2005; 40(3):395-404. PubMed ID: 15776985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    George J; Kinner SA; Bruno R; Degenhardt L; Dunn M
    Drug Alcohol Rev; 2010 May; 29(3):243-9. PubMed ID: 20565515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative experiences on Ecstasy: the role of drug, set and setting.
    McElrath K; McEvoy K
    J Psychoactive Drugs; 2002; 34(2):199-208. PubMed ID: 12691210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.
    Yacoubian GS; Boyle C; Harding CA; Loftus EA
    J Drug Educ; 2003; 33(2):187-96. PubMed ID: 12929709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends.
    Edland-Gryt M; Sandberg S; Pedersen W
    Int J Drug Policy; 2017 Dec; 50():1-8. PubMed ID: 28869878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivations for Selling Ecstasy among Young Adults in the Electronic Dance Music Club Culture in Brazil.
    Remy LS; Buttram ME; Kurtz SP; Surratt HL; Pechansky F
    J Psychoactive Drugs; 2017; 49(5):420-426. PubMed ID: 28692339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.